PET Drug Research Still In FDA's Enforcement Crosshairs As Columbia University Draws Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
While FDA is trying to make the approval process for PET drugs easier, that doesn't spare sponsors the responsibility to follow the rules.